Alseres Pharmaceuticals Inc /De

CIK 94784 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alseres Pharmaceuticals Inc /De.

Recent SEC filings

FiledFormAccession number
Nov 21, 20148-K0001193125-14-421780
Nov 18, 201415-12G0001193125-14-416637
Aug 14, 201410-Q0001193125-14-309279
May 23, 201410-Q0001193125-14-211193
May 16, 2014NT 10-Q0001193125-14-202267
Apr 10, 201410-K0001193125-14-137904
Mar 31, 2014NT 10-K0001193125-14-124102
Jan 6, 20148-K0001193125-14-002878
Dec 17, 20138-K0001193125-13-475540
Nov 14, 201310-Q0001193125-13-442102
Aug 9, 201310-Q0001193125-13-328326
Jul 31, 20138-K0001193125-13-311553
May 17, 201310-Q0001193125-13-225865
May 16, 2013NT 10-Q0001193125-13-224011
Apr 1, 201310-K0001193125-13-136073
Feb 21, 20138-K0001193125-13-069124
Feb 7, 20138-K0001193125-13-042319
Jan 28, 2013SC 13G/A0001041885-13-000024
Jan 28, 2013SC 13G/A0001041885-13-000028
Jan 8, 20138-K0001193125-13-006309
Nov 14, 201210-Q0001193125-12-468653
Aug 13, 201210-Q0001193125-12-350936
Aug 6, 20128-K0001193125-12-337700
Jul 23, 20128-K0001193125-12-309135
Jul 2, 20128-K0001193125-12-290921